share_log

4: Statement of changes in beneficial ownership of securities-Officer Chung Kevin

4: Statement of changes in beneficial ownership of securities-Officer Chung Kevin

4：持股變動聲明-高管 Chung Kevin
美股SEC公告 ·  10/02 04:51

牛牛AI助理已提取核心訊息

Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp (ICU), completed a purchase of 1,000 shares of common stock on September 30, 2024. The transaction was carried out on the open market at a price of $4.2581 per share. Following this acquisition, Chung's direct holdings in the company increased to a total of 9,435 shares of common stock. The transaction reflects a vested interest in the company's performance by one of its top executives.
Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp (ICU), completed a purchase of 1,000 shares of common stock on September 30, 2024. The transaction was carried out on the open market at a price of $4.2581 per share. Following this acquisition, Chung's direct holdings in the company increased to a total of 9,435 shares of common stock. The transaction reflects a vested interest in the company's performance by one of its top executives.
SeaStar Medical Holding Corp（ICU）的首席醫療官Kevin Chung在2024年9月30日完成了購買1,000股普通股的交易。該交易在股票市場以每股4.2581美元的價格進行。在此次收購之後，Chung在該公司的直接持股增加到總共9,435股普通股。該交易反映了公司高管之一對公司表現的已獲利益。
SeaStar Medical Holding Corp（ICU）的首席醫療官Kevin Chung在2024年9月30日完成了購買1,000股普通股的交易。該交易在股票市場以每股4.2581美元的價格進行。在此次收購之後，Chung在該公司的直接持股增加到總共9,435股普通股。該交易反映了公司高管之一對公司表現的已獲利益。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間